By HIMSS TV | February 29, 2024 | 6:00 AM Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, says the acquisition of drug-diversion company Invistics is helping to route appropriate medications to the right patients. Topic: Strategic Planning, Pharmacy, Patient Engagement, Mergers & Acquisitions, Business Intelligence, Artificial Intelligence